NEW YORK, NY (MARKET WIRE) U.S. primary care physicians (PCPs) have returned to expressing positive word of mouth about the pharmaceuticals industry, while in the main EU markets PCPs' attitudes to the industry are still fairly negative. Among oncologists, only those in the UK express a strongly favorable attitude toward the industry, according to new research from Kantar Health, a leading healthcare-focused global consultancy and marketing insights company.